Biohaven Pharmaceutical Holding (BHVN) PT Raised to $59 at BTIG
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $13.84 -4.29%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
BTIG analyst Thomas Shrader raised the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $59.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Suncrete Inc (RMIX) PT Lowered to $22 at Jefferies
- Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
